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Edited by Robert BaroukiAbstract Recently a novel family of putative nitric oxide syn-
thases, with AtNOS1, the plant member implicated in NO pro-
duction, has been described. Here we present experimental
evidence that a mammalian ortholog of AtNOS1 protein func-
tions in the cellular context of mitochondria. The expression data
suggest that a candidate for mammalian mitochondrial nitric
oxide synthase contributes to multiple physiological processes
during embryogenesis, which may include roles in liver haemato-
poesis and bone development.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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ortholog1. Introduction
In mammals, three highly homologous isoforms of nitric
oxide synthase (NOS) catalyze oxidation of L-arginine to nitric
oxide and L-citruline. NOS enzyme is composed of a catalytic
heme-containing oxygenase domain (NOSoxy) [1] and a sulﬁte
reductase ﬂavoprotein-like domain (NOSred) [2,3]. Both do-
mains are linked via a helical CaM-binding peptide [4,5]. Inter-
estingly, a gene homologous to the NOSoxy domain was
identiﬁed in a number of prokaryotes [3,6]. Yet a homologue
of the mammalian NOS gene is absent from up-to-date se-
quenced genomes of plants and single cellular eukaryotes
(i.e., yeast).
Intriguingly, recent reports hinted a possibility that a novel
NO source is at play. In the ﬁrst, the authors described a HelixAbbreviations: mAtNOS1, mouse ortholog of AtNOS1; hAtNOS1,
human ortholog of AtNOS1; mtNOS, mitochondrial nitric oxide
synthase; NADPH, nicotinamide adenine dinucleotide
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doi:10.1016/j.febslet.2005.12.038pomatia (snail) gene that, when over-expressed in Escherichia
coli, increases NOS activity in crude extracts [7]. Subsequently,
its plant ortholog, AtNOS1, was found to be associated with
arginine-dependent NO production in Arabidopsis [8]. This
ﬁnd triggered the description of a novel family of putative
NOS with members in virtually all organisms from bacteria
to humans [9]. Curiously, these proteins display no homology
to already known animal NOSs and contain a centrally posi-
tioned GTP-binding domain.
As the ﬁrst steps in our ongoing eﬀort to functionally char-
acterize mammalian members of this peculiar protein family,
we cloned the mouse AtNOS1 ortholog, mAtNOS1, and ana-
lysed its subcellular localization and expression domain.2. Materials and methods
2.1. Protein constructs
mAtNOS1 coding sequence (693 a.a.) was RT-PCR derived on a
template of RZPD cDNA clone (GI:16877844) and subcloned into
pcDNA3.1 vector.
Primer sequences used for cloning a full length ORF, D(1–26)mAt-
NOS1-V5 and D(1–56)mAtNOS1-V5 N-terminus deletion mutants of
mAtNOS1, and (1–60)mAtNOS1-EGFP fusion protein are listed in
the method section of Supplementary Information.
2.2. Cell lines and cell transfection
COS-1 and NIH3T3 cells were grown on Dulbecco’s modiﬁed Ea-
gle’s high glucose medium (DMEM) supplemented with 5% fetal calf
serum (FCS), penicillin (100 U/ml) and streptomycin (100 lg/ml).
Transfection was done using PolyFect (Qiagen).
2.3. Immunoﬂuorescence and microscopy
COS-1 and NIH3T3 cells were grown on coverslips and ﬁxed 48 h
after transfection with 4% paraformaldehyde for 10 min at room tem-
perature. The cells were permeabilized with 0.2% Triton X-100 in
PBS and incubated with primary antibody diluted in PBS, 10% FCS
and 0.05% NaN3 for 1 h at room temperature. For the MitoTracker

Red CM-H2Xros staining, the cells were ﬁxed and permeabilized with
ice-cold methanol for 10 min at 20 C. Secondary antibodies were di-
luted in PBS, 10% FCS and 0.05% NaN3 and incubated on coverslips
for 1 h at room temperature. The coverslips were mounted on slides
in Fluoromount-G (Electron Microscopy Sciences). The samples were
examined with a ﬂuorescence microscope Axiovert-200 (Zeiss) and pro-
cessed with deconvolution algorithm using Axio Vision 4.3 software.blished by Elsevier B.V. All rights reserved.
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and 0.2% glutaraldehyde for 1 h, dehydrated in an ethanol series and
embedded in LR-White or LR-Gold (London Resin Company). For
embedding in LR-Gold Resin, cells were grown on poly-lysine-coated
Thermanox coverslips (13 mm diameter; Nunc, Naperville, IL). For
embedding in LR-White Resin, cells grown in 10 cm culture dish were
ﬁxed and harvested with cell scraper. Post-embedded immunogold
labelling was performed using the rabbit-anti-V5 antibody (1:50) fol-
lowed by secondary antibody conjugated with 10 nm gold (1:100; Brit-
ish Bio Cell). The samples were viewed in a Philips CM 100 electron
microscope.
2.4. Cell fractionation and Western blotting
Citrate synthase (CS) and lactate dehydrogenase (LDH) activities in
the cytosolic as well as in the mitochondrial fraction were measured as
previously described [10,11]. Subcellular fractionation of COS-1 cells
was performed using cytosol/mitochondria fractionation kit (Onco-
gene) according to the following protocol. Cells were grown as adher-
ent cultures in 75 cm2 tissue culture bottles with DMEM supplemented
with 10% FCS. At near conﬂuence the cells were harvested by trypsi-
nation and washed twice with ice-cold extraction buﬀer (10 mM
HEPES, pH 7.5, 200 mM mannitol, 70 mM sucrose, 1 mM EGTA).
This yielded approximately 107 cells. From here all steps were per-
formed at 4 C. The cell pellet was re-suspended in 2 ml extraction buf-
fer supplemented with 2 mg/ml albumin and the cells were disrupted by
eight slow up- and down strokes through a tightly ﬁtting Teﬂon pestle
rotating in a Potter-Elevhjem homogenizer at 500 rpm. The homoge-
nate was transferred into 2 ml Eppendorf tubes and centrifuged atFig. 1. Alignment of the N-terminal sequences of mammalian AtNOS1 orth
taurus; CF, Canis familiaris; RN, Rattus norvegicus (GI: 34876747); MM
uncharged polar; red, charged polar; purple, negatively charged.
Fig. 2. Mitochondrial localization of mAtNOS1. COS1 cells, transiently tr
immunostained with mouse anti-V5 antibody (Invitrogen) and rabbit anti-Pro
Fluor 488 and anti rabbit-IgG Alexa Fluor 546 conjugated secondary antibo
MitoTracker Red CM-H2Xros (D–F).600 · g for 5 min to remove the cell nuclei. The supernatant was then
transferred into a new tube and centrifuged at 11000 · g for 10 min.
The supernatant was carefully removed and collected as the cytosolic
fraction and the remaining mitochondrial pellet was re-suspended in
storage buﬀer (10 mM HEPES, pH 7.4, 250 mM sucrose, 1 mM
ATP, 0.08 mM ADP, 5 mM sodium succinate, 2 mM K2HPO4,
1 mM DTT).
Finally, the protein content of the cytosolic and of the mitochondrial
fraction were measured with a standard BCA assay. Proteins in cyto-
solic and mitochondrial fractions were solubilized in Laemmli buﬀer,
resolved on 10% polyacrylamide gel and transferred onto PVDF
(Amersham). Immunoblots were developed using ECL detection sys-
tem (Amersham).
The following antibodies were used in immunoﬂuorescence and/or
WB analyses: mouse anti-V5 IgG2a (Invitrogen); goat anti-mouse
IgG Peroxidase Conjugated (Calbiochem); goat anti-rabbit IgG Perox-
idase Conjugated (Oncogene); rabbit anti-Prohibitin IgG polyclonal
ab2996 (Abcam); mouse anti cytochrome C IgG clone 7H8.2C12
(Pharmingen); goat anti-mouse IgG Alexa Flour-546 (Molecular
Probes); goat anti-mouse IgG Alexa Flour-488 (Molecular Probes);
rabbit anti-Actin A2066 (Sigma).
2.5. In situ hybridization
Section in situ hybridization on frozen E12.5 embryos was done with
digoxygenin labelled rRNA probe according to protocols of the Gene-
Paint system (Tecan) [12]. Section in situ hybridization on E14.5 em-
bryos was performed on paraﬃn embedded tissue using 33P labelled
cRNA-probes as described previously [13].ologs. HS, Homo sapiens (GI: 14150078); PT, Pan troglodytes; BT, Bos
, Mus musculus (GI: 9790049). Residues in blue, non-polar; yellow,
ansfected with V5-His-tagged mAtNOS1 (A–F) cultured for 48 h and
hibitin antibody – ab2996 (Abcam) followed by anti mouse-IgG Alexa
dies, respectively (A–C). Alternatively, mitochondria were stained with
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Total RNA was isolated from fresh homogenized tissue samples
using Total RNA isolation kit (AABiot, Gdynia, Poland) and electro-
phoresed (10 lg/lane) through 1% formaldehyde gel. RNA was trans-
ferred to Hybond N+ membrane (Amersham) and UV cross-linked
with UV-Stratalinker (Stratagene). The mAtNOS1 probe comprising
the PCR-derived full coding sequence region was labelled with [32P]
dCTP using Megaprime DNA labelling system (Amersham Biosci-
ences).3. Results and discussion
3.1. N-terminal signalling peptide
Initial analyses of the putative NOS family showed that
eukaryotic sequences, when compared to bacterial, are longer
in their N-terminus [9]. Our closer examination of the N-termi-
nal regions of mammalian sequences revealed enrichment in
charged residues, particularly arginines (Fig. 1). The latter is
a common feature of leader peptides [14]. To investigate this
matter further, we employed a tool, Target-P, that predicts
the subcellular location of eukaryotic proteins [15]. Strikingly,
all mammalian N-terminal peptides were classiﬁed, with a highFig. 3. mAtNOS1 exhibits intramitochondrial localization. COS1 cells, trans
processed for EM-immunostaining with LR white resin (A) or LR gold resin
with mouse anti-V5 antibody as described in Section 2. Colloidal gold particle
(B,C; arrows). Only very few particles, corresponding to the background, a
endoplasmic reticulum.probability (i.e., for the human sequence: Target-P score >0.9,
RC = 1), as the mitochondrial targeting peptides. With those
matters settled, we aimed for experimental validation of the
generated predictions.
3.2. Subcellular localization of mAtNOS1
First, we constructed a fusion gene, mAtNOS1-V5, in which
His-V5 tag was attached at the C-terminus of mAtNOS1 cod-
ing sequence (693 a.a.). This allowed us to examine the subcel-
lular localization of mAtNOS1-V5 in transiently transfected
COS-1 and NIH3T3 cells. Immunolabelling with anti V5-
antibody revealed a mitochondrial pattern of distribution,
subsequently conﬁrmed by co-immunodetection with anti-Pro-
hibitin antibody and staining with a mitochondrial marker
MitoTracker (Fig. 2). Having established that, we further ex-
plored the localization of mAtNOS-V5 by immune-gold elec-
tron microscopy. Fig. 3 clearly shows that the protein
localizes to the inner-mitochondria compartment. Since colloi-
dal gold particles were frequently found within the mitochon-
dria cristae (Fig. 3B and C), we ﬁnd it highly plausible that the
inner mitochondria membrane is the primary site of mAtNOS1
localization.iently transfected with V5-His-tagged mAtNOS1, cultured for 48 h and
(B,C) – see Section 2 for a detailed protocol. Cells were immunostained
s are frequently associated with the cristae membranes of mitochondria
re present outside mitochondria (A). M – mitochondria; RER – raw
Fig. 4. The N-terminus of mAtNOS1 contains a mitochondrial targeting signal. COS1 cells, transiently transfected with D(1–26)mAtNOS1-V5
(A–C), (1–60)mAtNOS1-EGFP (D–F) and EGFP (G–I), cultured for 48 h and stained with mitochondria speciﬁc marker MitoTracker Red
CM-H2Xros (A–I). (A–C) Green ﬂuorescence from immunostaining with mouse anti-V5 antibody (Invitrogen) and anti mouse-IgG Alexa Fluor 488.
(D–I) Green ﬂuorescence from EGFP.
Fig. 5. N-terminus dependent enrichment of mAtNOS1 in mitochon-
dria. Cytosolic (lanes 1 and 2) and mitochondrial (lanes 3 and 4)
distribution of the V5-His-tagged mAtNOS1 protein was analyzed by
Western blotting. COS1 cells were transiently transfected with mAt-
NOS1 (lanes 1 and 3), and D(1–56)mAtNOS1-V5 (lanes 2 and 4)
constructs and fractionated into mitochondria-enriched and cytosolic
fractions using cytosol/mitochondria fractionation kit (Oncogene
Research Products). Western blots were followed by immunodetection
with antibodies against V5 epitope, prohibitin, cytochrome C and
actin. Activity (in U/g of protein) of cytosolic LDH and mitochondrial
CS in each fraction is presented as mean ± S.D.
458 T. Zemojtel et al. / FEBS Letters 580 (2006) 455–4623.3. The amino terminus of mAtNOS1 contains a mitochondrial
targeting signal
In order to test if the N-terminal sequence encodes a mito-
chondrial targeting peptide, we constructed deletion mutants
devoid of 26 and 56 amino acids at the N-terminus, D(1–
26)mAtNOS1-V5 and D(1–56)mAtNOS1-V5, respectively.
Both mutant proteins no longer co-localized with MitoTrac-
ker and exhibited a diﬀuse distribution in the transient trans-
fected COS1 and 3T3NIH cells (Fig. 4, Fig. S1, result for D(1–
56)mAtNOS1-V5 not shown). This notion is further supported
by a fractionation experiment, in which a signiﬁcant enrich-
ment of D(1–26)mAtNOS1-V5 and D(1–56)mAtNOS1-V5 mu-
tants was observed in the cytoslic fractions, as compared to the
mitochondrial fractions of COS1 cells (Fig. 5, results for D(1–
26)mAtNOS1-V5 not shown).
In order to further study the involvement of N-terminus in
the subcellular localization of the protein, we transfected
COS-1 cells with a construct encoding a fusion between amino
acids 1–60 of mAtNOS1 and enhanced green ﬂuorescent pro-
tein (EGFP). Markedly, (1–60)mAtNOS1-EGFP fusion gene
co-localized with MitoTracker in COS1 and NIH3T3 cells
(Fig. 4, Fig. S1). Thus, our results indicate that the ﬁrst 60 ami-
no acids of mAtNOS1 contain a mitochondrial targeting signal
that is necessary and suﬃcient for import into mitochondria.
Fig. 6. Expression of mAtNOS1 at E12.5. In situ hybridization of digoxygenin labeled probe on OCT frozen parasagittal sections of E12.5 wild-type
embryo. Expression is detected in the developing central and peripheral nervous system as well as in the liver. Magniﬁed areas of intense expression in
the neopallial cortex and liver, B and C, respectively. Dorsal root ganglia (DRG), roof of midbrain (RMB), liver (L), neopallial cortex (NC).
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Next, we analysed the embryonic expression pattern of
mAtNOS1 gene. Whole-mount in situ hybridization experi-
ments at E10.5 revealed a weak, but widespread expression
of mAtNOS1 (data not shown). In situ hybridization on
frozen mouse embryonic sections at later stage of gestation,
E12.5, showed prominent expression of mAtNOS1 in the li-
ver (Fig. 6). The latter may be indicative of its function in
embryonic liver haematopoesis. In addition, mAtNOS1 was
detected in the developing CNS and dorsal root ganglia.
Interestingly, at E14.5 mAtNOS1 expression was intensiﬁed
in the bone (Fig. 7). On the coronary sections of E14.5
mouse embryo, expression was detected in the ossiﬁed parts
of the ribs, whereas no expression could be seen in the
cartilaginous parts. Also at the longitudinal sections through
E14.5 embryo humerus, mAtNOS1 expression was observed
in the ossiﬁcation zone but not in the cartilage, supporting
the notion that bone cells and not chondrocytes express
mAtNOS1 (Supp. Fig. 2). In summary, in situ hybridization
data is suggestive of a role for mAtNOS1 in development of
neural, haematopoietic and bone organ systems.
We also explored the question of whether the gene is
expressed in established bone cell lines. Interestingly, North-
ern blot detected mAtNOS1 mRNA in primary calvaria
osteoblasts, as well as established stroma (ST-2), pre-osteo-
blastic (MC3T3-E1), osteocyte (MLOY4) and multipotent
mesenchymal (C3H10T1/2) cell lines (Fig. 8). Lastly, we
probed total RNA from adult mouse organs for mAtNOS1
expression. Northern blot revealed that the gene was
expressed in the organs associated with high mito
chondria content, like testes, heart, liver, brain and thymus
(Fig. 8).4. Summary and outlook
We showed that mouse AtNOS1 ortholog, mAtNOS1, local-
izes to mitochondria. It can be expected, on the bases of a high
sequence similarity in the regions corresponding to the N-ter-
minal targeting peptide (Fig. 1), that all of mammalian
AtNOS1 orthologs are mitochondrial proteins. Moreover,
according to Target-P predictions, Arabidopsis sequence,
AtNOS1, is also a mitochondrial protein (Target-P score of
0.8), suggesting a conservation of the subcellular localization
among eukaryota. Indeed, while the present study was in re-
view, Guo et al. reported that Arabidopsis AtNOS1 protein,
a like its mammalian ortholog, mAtNOS1, is also targeted to
mitochondria [16]. Moreover, the mitochondria isolated from
the AtNOS1 mutant plant (AtNOS1 /) were defective in
L-Arg based NO production. Elevated levels of hydrogen per-
oxide, superoxide anion, oxidized lipid, and oxidized proteins
were detected in the AtNOS1 / plant.
This set of ﬁndings is especially interesting in the light of
the ongoing debate on existence of a mammalian mitochon-
drial NOS (mtNOS) [17–19]. mtNOS has been described as
an L-arginine and Ca2+ dependent enzyme that is associated
with the mitochondrial inner membrane and regulates mito-
chondrial respiration via produced NO [20–23]. It is note
worthy that NO has been shown to stimulate biogenesis of
respiratory functional and metabolically active mitochondria
[24]. Subsequently, multiple groups, by utilizing antibodies
raised against the nicotinamide adenine dinucleotide
(NADPH)-binding C-terminus of classical NOSs, identiﬁed
eNOS [21,25,26], iNOS [27] and nNOS [28–30] as mitochon-
drial NOS (for a detailed discussion see reviews [17–19]). Still,
others did not detect nNOS nor iNOS in the mitochondria,
Fig. 7. Expression of mAtNOS1 at E14.5. In situ hybridization on coronary and parasagittal paraﬃn sections of E14.5 wild-type embryos. Left panel
shows the bright ﬁeld image, right panel the dark ﬁeld. mAtNOS1 expression is seen in the ossiﬁcation zone within the shaft of the humerus (A–A 0),
the primordium of basioccipital bone (B–B 0), the rib primordia (C–C0) and in primordia of incisor teeth (D–D 0).
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[31].
Are mammalian AtNOS1 orthologs the long-sought
mtNOS? To date, the NOS activity has been documented for
Arabidopsis AtNOS1 protein [8]. However, for the latter, a cat-
alytic mechanism of NO production is still not known. Inter-
estingly, sequences belonging to the novel, putative NOSfamily, including AtNOS1 member, contain within their N-ter-
minus a treble clef ﬁnger-like motif CxxC–x(26–34)–CxxC [9]
known to be involved in metal binding [32]. The latter may
constitute an active site or electron acceptor site. The study
on Arabidopsis AtNOS1 protein revealed that NOS activity
was dependent on NADPH [8]. Intriguingly, the NADPH-
binding site appears to be absent in AtNOS1 sequence. A pos-
Fig. 8. Northern blot analysis of mAtNOS1 in adult mouse organs
and mesenchymal, stromal, osteoblastic and osteocytic cell lines. The
28S and 18S rRNAs are indicated on the right side. Upper panel –
hybridization with mAtNOS1 speciﬁc probe. Samples are in the
following order: placenta (1), liver (2), kidney (3), lungs (4), testes (5),
heart (6), brain (7), thymus (8), spleen (9) and stomach (10), primary
calvaria osteoblasts (11), ST2 – stroma cell line (12), MC3T3 pre-
osteoblastic cell line (13), C3H10T1/2 multipotent mesenchymal cell
line (14), MLOY4 osteocytic cell line (15). Lower panel – loading
control: ethydium bromide stained membrane.
T. Zemojtel et al. / FEBS Letters 580 (2006) 455–462 461sible explanation is, that a NADPH-dependent electron donat-
ing system, such as a ﬂavoprotein, might interact with At-
NOS1 and thus might have been copuriﬁed with the
AtNOS1 protein from E. coli.
What might be the electron donating partner in vivo? Local-
ization of mAtNOS1 in a vicinity of the inner mitochondrial
membrane (Fig. 3) might imply interaction with components
of mitochondrial electron chain. Indeed, studies in yeast but
also in alga, both lacking the classical NOS gene, point to
involvement of the mitochondrial electron transport system
in NO production [33,34]. In this light, it is tempting to spec-
ulate that eukaryotic orthologs of AtNOS1 may link the mito-
chondrial electron transport system with NO production.
Currently, we are in a process of puriﬁcation of mAtNOS1,
hAtNOS1, and identiﬁcation of their mitochondrial interac-
tion partners. In addition, generation of a mAtNOS1 knock-
out mouse will help us to further deﬁne the physiological
role of this novel candidate for mitochondrial NOS in
mammals.
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